- If India were to join the mega-regional Free Trade Agreement (FTA) called the Trans-Pacific Partnership (TPP) and adopt its norms, they would severely hurt the country’s agriculture, manufacturing, services and the generic pharma industry, according to a new book.
- U.S. had withdrawn from the TPP early last year.
- The other 11 countries (Japan, Australia, Canada, New Zealand, Singapore, Malaysia, Brunei, Mexico, Peru, Chile and Vietnam).
- According to the book, if India were to conform to the TPP template of rules on market access in goods, it would pose severe challenges to India’s manufacturing sector.
- The domestic industry may not be able to face import competition in a duty-free regime, it added.
- On the agriculture front, the farmers will be continuously exposed to the risk of being knocked out of the market by cheap and subsidised exports, particularly from the U.S., Australia and New Zealand.
- The TPP template may pose severe challenges to the government in regulating services in the future, the book claimed.
- The TPP also “would severely restrict the entry into the market, or the reimbursement for use, of generic medicine.
- If India were to adopt [TPP] rules, it would require significant changes in the domestic regulatory regime.
- India’s export prospects in government procurement markets may continue to below, if it entered the pact.